PFPG
SNDX icon

Pinnacle Financial Partners (Georgia)’s Syndax Pharmaceuticals SNDX Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.75M Buy
217,173
+14,891
+7% +$310K 0.03% 334
2026
Q1 		$4.73M Sell
202,282
-4,319
-2% -$93.8K 0.04% 310
2025
Q4 		$4.34M Buy
+206,601
New +$3.6M 0.03% 316

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s SNDX Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) increased its Syndax Pharmaceuticals (SNDX) stake by 7.4% in Q2 2026, buying an estimated $310K and bringing the position to 217,173 shares worth $4.75M. The position accounts for 0.03% of the portfolio, ranked #334.

Pinnacle Financial Partners (Georgia) first reported a position in SNDX in Q4 2025 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 217,173 shares of Syndax Pharmaceuticals worth $4.75M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) bought 14,891 Syndax Pharmaceuticals shares in Q2 2026, an estimated $310K.
  • Syndax Pharmaceuticals made up 0.03% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #334 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Syndax Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.